# 焦虑

[◀返回](./home.md)

**焦虑**在医学上被认定为经历忧虑、担心和普遍不安的消极感觉哦[\[1\]](#cite_note-DSM5GlossaryAnxiety-1)[\[2\]](#cite_note-ICD-11-Anxiety-2)。这些感觉的范围可以从细微且容易被忽略的，到强烈且压倒性得足以引发[恐慌发作](/药效/恐慌发作.md)或[厄运感](/药效/厄运感.md)呢。焦虑通常伴随着紧张的行为，比如[刺激](/药效/刺激.md)、坐立不安、[注意力难以集中](/药效/注意力抑制.md)、[易怒](/药效/易怒.md)和[肌肉紧张](/药效/肌肉紧张.md)[\[3\]](#cite_note-DSM5AnxietyDisorders-3)。精神活性物质引发的焦虑可能是药物本身无法避免的效应，也可能是因为对该物质或其强度缺乏经验，或者是对原有心理状态的强化，或者是经历了负面的幻觉造成的。预感到的危险焦点可能来自内部，也可能来自外部哦。

焦虑通常伴随着其他效应，比如[抑郁](/药效/抑郁.md)和[易怒](/药效/易怒.md)呢。它最常在[中等](/文档/药物剂量分类.md#common)[剂量](/文档/给药剂量.md)的[致幻](/文档/药物分类/致幻剂.md)化合物影响下被诱发，比如[大麻类](/文档/药物分类/大麻类.md)[\[4\]](#cite_note-CrippaZuardi2009-4)、[迷幻剂](/文档/药物分类/迷幻剂.md)[\[5\]](#cite_note-WolbachMiner1962-5)、[解离剂](/文档/药物分类/解离剂.md)和[谵妄剂](/文档/药物分类/谵妄剂.md)[\[6\]](#cite_note-6)。不过嘛，它也可能在[GABA能](/文档/药物分类/GABA.md)[抑制剂](/文档/药物分类/抑制剂.md)的戒断症状期间[\[7\]](#cite_note-7)以及[兴奋剂](/文档/药物分类/兴奋剂.md)药效消退时出现[\[8\]](#cite_note-Williamson1997-8)。

如果你感到焦虑，你可能想读读[焦虑抑制](/药效/焦虑抑制.md)这个效应呢。另外，如果焦虑严重影响了长时间的幸福感，强烈建议寻求医疗关注和/或支持小组的帮助哦。

### 分析

恐惧不是焦虑哟[\[2\]](#cite_note-ICD-11-Anxiety-2)[\[3\]](#cite_note-DSM5AnxietyDisorders-3)[\[9\]](#cite_note-BarkusMcHugh2010-9)[\[10\]](#cite_note-Tovote2015-10)[\[11\]](#cite_note-Grupe2013-11)[\[12\]](#cite_note-LeDoux2016-12)。恐惧是对眼前威胁的反应，而焦虑是一组试图减轻感知道的未来威胁的行为。焦虑症是一种非典型的适应不良行为的学习。虽然有大量证据表明焦虑症涉及遗传和早期环境因素，但焦虑的想法和行为模式的练习也会进一步加强相关的神经通路。讽刺的是，试图回避引发焦虑的行为线索，反而会保护引发焦虑的神经通路不被熄灭呢。

恐惧和焦虑是防御性神经网络，涉及许多功能独特的枢纽[\[10\]](#cite_note-Tovote2015-10)[\[11\]](#cite_note-Grupe2013-11)[\[12\]](#cite_note-LeDoux2016-12)[\[13\]](#cite_note-Stahl2013-13)。虽然恐惧和焦虑在这些防御网络中有很大的重叠，但它们确实是不同的哦。通常杏仁核和终纹床核分别是恐惧和焦虑的焦点，但在指定这些作为主要中心时存在显著的问题。这些枢纽产生信号来修改适当的防御性神经通路，但它们不是引发主观体验的中心。身体的防御反应出现在感觉到威胁的意识觉知之前，出现在没有感觉到威胁的意识觉知时，以及针对饥饿等生存线索时。自动防御反应不一定是意识感觉，这意味着焦虑成为主观体验涉及不同的神经通路。

由于涉及的大脑系统非常广泛，肠道细菌的影响[\[14\]](#cite_note-14)，以及这些系统之间任何潜在的沟通故障，在临床医生背景之外描述焦虑的潜在神经解剖学并没有太大用处。但是，在焦虑个体中有特定的可观察倾向哦[\[11\]](#cite_note-Grupe2013-11)：

*   对威胁成本和可能性的估计过高
*   增加的威胁关注和过度警觉
*   受损的安全线索识别
*   行为和认知回避
*   对威胁不确定性的反应性增高

焦虑症是最常见的一类精神障碍；三分之一的人口在一生中都会受到焦虑症的影响[\[15\]](#cite_note-15)。一致发现女性的患病率是男性的两倍呢。患者可能会受这种疾病困扰数年到数十年，但这并不意味着它是永久性的哦。在稍微不同的焦虑症分类之间，以及焦虑症与其他精神障碍之间存在很高的重叠。重要的是要记住，焦虑的存在是一种正常的防御机制。当焦虑严重影响了长时间的功能性幸福感时，它就变成了焦虑症。

### 体验报告

在我们的[体验报告](/报告/psychounautwiki/)中，描述了这种效应的轶事报告包括：

*   [Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)](/报告/psychounautwiki/Experience:_22mg_2C-B_(oral)_/_100ug_1P-LSD_(sublingual)_-_My_first_time_tripping_alone_(2_days_in_a_row))
*   [Experience: 660ug LSD - First bad trip](/报告/psychounautwiki/Experience:_660ug_LSD_-_First_bad_trip)
*   [Experience: LSD (Unknown dosage) - My experiences with LSD and anorexia/bulemia](/报告/psychounautwiki/Experience:_LSD_(Unknown_dosage)_-_My_experiences_with_LSD_and_anorexia/bulemia)
*   [Experience: Ritalin 110mg (oral)](/报告/psychounautwiki/Experience:_Ritalin_110mg_(oral))
*   [Experience:100-350mg - Phenylpiracetam in daily life](/报告/psychounautwiki/Experience:100-350mg_-_Phenylpiracetam_in_daily_life)
*   [Experience:120µg LSD - First Bad Acid Trip, Psychosis](/报告/psychounautwiki/Experience:120%C2%B5g_LSD_-_First_Bad_Acid_Trip,_Psychosis)
*   [Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself](/报告/psychounautwiki/Experience:150mg_MDMA_%2B_20mg_2C-B_-_I_designed_it_this_way_myself)
*   [Experience:17mg 3-MeO-PCP & Cannabis oil - Terrifying confusion](/报告/psychounautwiki/Experience:17mg_3-MeO-PCP_%26_Cannabis_oil_-_Terrifying_confusion)
*   [Experience:1g Methiopropamine - Chasing the Chalky Dragon](/报告/psychounautwiki/Experience:1g_Methiopropamine_-_Chasing_the_Chalky_Dragon)
*   [Experience:2 grams Psilocybe Cubensis + 2.7 grams Syrian Rue - The Psilohuasca Albino Fox](/报告/psychounautwiki/Experience:2_grams_Psilocybe_Cubensis_%2B_2.7_grams_Syrian_Rue_-_The_Psilohuasca_Albino_Fox)
*   [Experience:2 x 150 LSD tabs](/报告/psychounautwiki/Experience:2_x_150_LSD_tabs)
*   [Experience:2.5g Peganum Harmala + 250µg LSD - Ecstasy of Love and Misanthropy](/报告/psychounautwiki/Experience:2.5g_Peganum_Harmala_%2B_250%C2%B5g_LSD_-_Ecstasy_of_Love_and_Misanthropy)
*   [Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)](/报告/psychounautwiki/Experience:2.5g_Syrian_rue_%2B_6g_Mimosa_Hostilis_-_Becoming_God_(my_second_experience_with_unity))
*   [Experience:20mg - I looked up and saw an angry god-like figure made of clouds glaring down at me](/报告/psychounautwiki/Experience:20mg_-_I_looked_up_and_saw_an_angry_god-like_figure_made_of_clouds_glaring_down_at_me)
*   [Experience:250 seeds - Harsh body load](/报告/psychounautwiki/Experience:250_seeds_-_Harsh_body_load)
*   [Experience:25mg Quetiapine - Nice buzz](/报告/psychounautwiki/Experience:25mg_Quetiapine_-_Nice_buzz)
*   [Experience:26mg - I begged the shroom aliens to kill me](/报告/psychounautwiki/Experience:26mg_-_I_begged_the_shroom_aliens_to_kill_me)
*   [Experience:26mg - Stage 3 Trip](/报告/psychounautwiki/Experience:26mg_-_Stage_3_Trip)
*   [Experience:3 drops of cinnamon bark oil/ 5 drops of german chamomile oil/ 2mL of nutmeg oil in lecithin - experiments with nutmeg oil](/报告/psychounautwiki/Experience:3_drops_of_cinnamon_bark_oil/_5_drops_of_german_chamomile_oil/_2mL_of_nutmeg_oil_in_lecithin_-_experiments_with_nutmeg_oil)
*   [Experience:3-MeO-PCP - Extreme psychosis](/报告/psychounautwiki/Experience:3-MeO-PCP_-_Extreme_psychosis)
*   [Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation](/报告/psychounautwiki/Experience:3.5g_psilocybe_cubensis_-_Relinquishing_of_Material_Chains/Fear_and_Desolation)
*   [Experience:3g - I found god inside of myself](/报告/psychounautwiki/Experience:3g_-_I_found_god_inside_of_myself)
*   [Experience:4 Days Sleep Deprivation - Progression of Sleep Deprivation Visuals Over Time](/报告/psychounautwiki/Experience:4_Days_Sleep_Deprivation_-_Progression_of_Sleep_Deprivation_Visuals_Over_Time)
*   [Experience:40mg DMT - Second breakthrough](/报告/psychounautwiki/Experience:40mg_DMT_-_Second_breakthrough)
*   [Experience:45mg 2cc & 45mg 4-aco-dmt - Ego death and loneliness](/报告/psychounautwiki/Experience:45mg_2cc_%26_45mg_4-aco-dmt_-_Ego_death_and_loneliness)
*   [Experience:50mg - How's the short-term memory?](/报告/psychounautwiki/Experience:50mg_-_How%27s_the_short-term_memory%3F)
*   [Experience:535mg - My First DXM Trip](/报告/psychounautwiki/Experience:535mg_-_My_First_DXM_Trip)
*   [Experience:A combination of 25mg 4-AcO-DMT and unknown amount of 6-APB (benzofury)](/报告/psychounautwiki/Experience:A_combination_of_25mg_4-AcO-DMT_and_unknown_amount_of_6-APB_(benzofury))
*   [Experience:DMT: 200mg 1/5 changa - Bad yet glorious trip](/报告/psychounautwiki/Experience:DMT:_200mg_1/5_changa_-_Bad_yet_glorious_trip)
*   [Experience:DPH (750 mg) - The Dancing Invisible Men Come to Life!](/报告/psychounautwiki/Experience:DPH_(750_mg)_-_The_Dancing_Invisible_Men_Come_to_Life!)
*   [Experience:DXM and Cannabis: 100mg - Unexpected Strong Trip](/报告/psychounautwiki/Experience:DXM_and_Cannabis:_100mg_-_Unexpected_Strong_Trip)
*   [Experience:Datura Alcoholic Tincture](/报告/psychounautwiki/Experience:Datura_Alcoholic_Tincture)
*   [Experience:FMA (37.5 mg, oral) - Never been this productive in my life](/报告/psychounautwiki/Experience:FMA_(37.5_mg,_oral)_-_Never_been_this_productive_in_my_life)
*   [Experience:LSD (230 ug) - An amazing adventure by vikilikepsych](/报告/psychounautwiki/Experience:LSD_(230_ug)_-_An_amazing_adventure_by_vikilikepsych)
*   [Experience:Meditation with cannabis - terminated ego loss](/报告/psychounautwiki/Experience:Meditation_with_cannabis_-_terminated_ego_loss)
*   [Experience:Mushrooms (~0.5 g) - Autonomous Voice](/报告/psychounautwiki/Experience:Mushrooms_(~0.5_g)_-_Autonomous_Voice)
*   [Experience:Nutmeg (8 teaspoons) - My Mom Introduces Me To Genesis and Other Things](/报告/psychounautwiki/Experience:Nutmeg_(8_teaspoons)_-_My_Mom_Introduces_Me_To_Genesis_and_Other_Things)
*   [Experience:Unknown Dosages: 1 psilocin chocolate, 1 hit LSD; Lawing the Mown](/报告/psychounautwiki/Experience:Unknown_Dosages:_1_psilocin_chocolate,_1_hit_LSD;_Lawing_the_Mown)
*   [Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death](/报告/psychounautwiki/Experience:Unknown_Dose_DOC_(Insufflated)_-_Overdosing_and_Terifying_Ego_Death)
*   [Experience:Unknown dose - Supermarket dislocation and biking](/报告/psychounautwiki/Experience:Unknown_dose_-_Supermarket_dislocation_and_biking)
*   [Experience:Zopiclone hppd?](/报告/psychounautwiki/Experience:Zopiclone_hppd%3F)

### 另见

*   [负责任的用药索引页](/文档/负责任的用药索引页.md)
*   [主观效应索引](/文档/科学信息索引页.md)
*   [恐慌发作](/药效/恐慌发作.md)
*   [焦虑抑制](/药效/焦虑抑制.md)
*   [谵妄剂 - 主观效应](/文档/药物分类/谵妄剂.md#Subjective_effects)
*   [迷幻剂 - 主观效应](/文档/药物分类/迷幻剂.md#Subjective_effects)
*   [解离剂 - 主观效应](/文档/药物分类/解离剂.md#Subjective_effects)
*   [益智药调查（焦虑/无焦虑对比）](/文件/AnxietyNootropics.png)

### 外部链接

*   [焦虑 (维基百科)](https://en.wikipedia.org/wiki/Anxiety)
*   [致焦虑剂 (维基百科)](https://en.wikipedia.org/wiki/Anxiogenic)
*   [抗焦虑药 (维基百科)](https://en.wikipedia.org/wiki/Anxiolytic)
*   [恐慌发作 (维基百科)](https://en.wikipedia.org/wiki/Panic_attack)

### 参考文献

1.  [↑](#cite_ref-DSM5GlossaryAnxiety_1-0) "Glossary of Technical Terms". *Diagnostic and statistical manual of mental disorders (5th ed.)*: 189–190. 2013. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1176/appi.books.9780890425596.GlossaryofTechnicalTerms](//doi.org/10.1176%2Fappi.books.9780890425596.GlossaryofTechnicalTerms).
2.  ↑ [2.0](#cite_ref-ICD-11-Anxiety_2-0) [2.1](#cite_ref-ICD-11-Anxiety_2-1) ["Anxiety or fear-related disorders"](https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1336943699). *International statistical classification of diseases and related health problems (11th ed.)*. 2022. Retrieved 20 May 2022.
3.  ↑ [3.0](#cite_ref-DSM5AnxietyDisorders_3-0) [3.1](#cite_ref-DSM5AnxietyDisorders_3-1) "Anxiety Disorders". *Diagnostic and statistical manual of mental disorders (5th ed.)*: 818. 2013. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1176/appi.books.9780890425596.dsm05](//doi.org/10.1176%2Fappi.books.9780890425596.dsm05).
4.  [↑](#cite_ref-CrippaZuardi2009_4-0) Crippa, José Alexandre; Zuardi, Antonio Waldo; Martín-Santos, Rocio; Bhattacharyya, Sagnik; Atakan, Zerrin; McGuire, Philip; Fusar-Poli, Paolo (2009). "Cannabis and anxiety: a critical review of the evidence". *Human Psychopharmacology: Clinical and Experimental*. **24** (7): 515–523. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1002/hup.1048](//doi.org/10.1002%2Fhup.1048). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0885-6222](//www.worldcat.org/issn/0885-6222).
5.  [↑](#cite_ref-WolbachMiner1962_5-0) Wolbach, A. B.; Miner, E. J.; Isbell, Harris (1962). "Comparison of psilocin with psilocybin, mescaline and LSD-25". *Psychopharmacologia*. **3** (3): 219–223. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1007/BF00412109](//doi.org/10.1007%2FBF00412109). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0033-3158](//www.worldcat.org/issn/0033-3158).
6.  [↑](#cite_ref-6) Datura effects (Erowid) | <https://erowid.org/plants/datura/datura_effects.shtml>
7.  [↑](#cite_ref-7) "Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment". *American Journal of Psychiatry*. **141** (7): 848–852. 1984. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1176/ajp.141.7.848](//doi.org/10.1176%2Fajp.141.7.848). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0002-953X](//www.worldcat.org/issn/0002-953X).
8.  [↑](#cite_ref-Williamson1997_8-0) Williamson, S (1997). "Adverse effects of stimulant drugs in a community sample of drug users". *Drug and Alcohol Dependence*. **44** (2-3): 87–94. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/S0376-8716(96)01324-5](//doi.org/10.1016%2FS0376-8716%2896%2901324-5). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0376-8716](//www.worldcat.org/issn/0376-8716).
9.  [↑](#cite_ref-BarkusMcHugh2010_9-0) Barkus, Christopher; McHugh, Stephen B.; Sprengel, Rolf; Seeburg, Peter H.; Rawlins, J. Nicholas P.; Bannerman, David M. (2010). "Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion". *European Journal of Pharmacology*. **626** (1): 49–56. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.ejphar.2009.10.014](//doi.org/10.1016%2Fj.ejphar.2009.10.014). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0014-2999](//www.worldcat.org/issn/0014-2999).
10. ↑ [10.0](#cite_ref-Tovote2015_10-0) [10.1](#cite_ref-Tovote2015_10-1) Tovote, P., Fadok, J. P., Lüthi, A. (June 2015). ["Neuronal circuits for fear and anxiety"](https://www.nature.com/articles/nrn3945). *Nature Reviews Neuroscience*. **16** (6): 317–331. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1038/nrn3945](//doi.org/10.1038%2Fnrn3945). Retrieved 21 May 2022.
11. ↑ [11.0](#cite_ref-Grupe2013_11-0) [11.1](#cite_ref-Grupe2013_11-1) [11.2](#cite_ref-Grupe2013_11-2) Grupe, D. W., Nitschke, J. B. (July 2013). ["Uncertainty and anticipation in anxiety: an integrated neurobiological and psychological perspective"](http://www.nature.com/articles/nrn3524). *Nature Reviews Neuroscience*. **14** (7): 488–501. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1038/nrn3524](//doi.org/10.1038%2Fnrn3524). Retrieved 21 May 2022.
12. ↑ [12.0](#cite_ref-LeDoux2016_12-0) [12.1](#cite_ref-LeDoux2016_12-1) LeDoux, J. E., Pine, D. S. (November 2016). ["Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework"](http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.16030353). *American Journal of Psychiatry*. **173** (11): 1083–1093. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1176/appi.ajp.2016.16030353](//doi.org/10.1176%2Fappi.ajp.2016.16030353). Retrieved 29 May 2022.
13. [↑](#cite_ref-Stahl2013_13-0) Stahl, S. M. (2013). *Stahl’s essential psychopharmacology: neuroscientific basis and practical application* (4th ed ed.). Cambridge University Press. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number") [9781107025981](http://en.wikipedia.org/wiki/Special:BookSources/9781107025981 "wikipedia:Special:BookSources/9781107025981"). CS1 maint: Extra text ([link](/w/index.php?title=Category:CS1_maint:_Extra_text&action=edit&redlink=1 "Category:CS1 maint: Extra text (page does not exist)"))
14. [↑](#cite_ref-14) Foster, J. A., McVey Neufeld, K.-A. (May 2013). ["Gut–brain axis: how the microbiome influences anxiety and depression"](https://linkinghub.elsevier.com/retrieve/pii/S0166223613000088). *Trends in Neurosciences*. **36** (5): 305–312. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.tins.2013.01.005](//doi.org/10.1016%2Fj.tins.2013.01.005). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0166-2236](//www.worldcat.org/issn/0166-2236). Retrieved 29 May 2022.
15. [↑](#cite_ref-15) Bandelow, B., Michaelis, S. (30 September 2015). ["Epidemiology of anxiety disorders in the 21st century"](https://www.tandfonline.com/doi/full/10.31887/DCNS.2015.17.3/bbandelow). *Dialogues in Clinical Neuroscience*. **17** (3): 327–335. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.31887/DCNS.2015.17.3/bbandelow](//doi.org/10.31887%2FDCNS.2015.17.3%2Fbbandelow). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1958-5969](//www.worldcat.org/issn/1958-5969). Retrieved 30 May 2022.
